These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
324 related items for PubMed ID: 17437547
1. Involvement of KCNQ2 subunits in [3H]dopamine release triggered by depolarization and pre-synaptic muscarinic receptor activation from rat striatal synaptosomes. Martire M, D'Amico M, Panza E, Miceli F, Viggiano D, Lavergata F, Iannotti FA, Barrese V, Preziosi P, Annunziato L, Taglialatela M. J Neurochem; 2007 Jul; 102(1):179-93. PubMed ID: 17437547 [Abstract] [Full Text] [Related]
2. M channels containing KCNQ2 subunits modulate norepinephrine, aspartate, and GABA release from hippocampal nerve terminals. Martire M, Castaldo P, D'Amico M, Preziosi P, Annunziato L, Taglialatela M. J Neurosci; 2004 Jan 21; 24(3):592-7. PubMed ID: 14736843 [Abstract] [Full Text] [Related]
3. The pharmacological effect of positive KCNQ (Kv7) modulators on dopamine release from striatal slices. Jensen MM, Lange SC, Thomsen MS, Hansen HH, Mikkelsen JD. Basic Clin Pharmacol Toxicol; 2011 Nov 21; 109(5):339-42. PubMed ID: 21599837 [Abstract] [Full Text] [Related]
4. Release-enhancing pre-synaptic muscarinic and nicotinic receptors co-exist and interact on dopaminergic nerve endings of rat nucleus accumbens. Grilli M, Patti L, Robino F, Zappettini S, Raiteri M, Marchi M. J Neurochem; 2008 Jun 01; 105(6):2205-13. PubMed ID: 18298664 [Abstract] [Full Text] [Related]
5. 5-HT1B receptors modulate release of [3H]dopamine from rat striatal synaptosomes: further evidence using 5-HT moduline, polyclonal 5-HT1B receptor antibodies and 5-HT1B receptor knock-out mice. Sarhan H, Grimaldi B, Hen R, Fillion G. Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan 01; 361(1):12-8. PubMed ID: 10651141 [Abstract] [Full Text] [Related]
6. Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine. Tatulian L, Delmas P, Abogadie FC, Brown DA. J Neurosci; 2001 Aug 01; 21(15):5535-45. PubMed ID: 11466425 [Abstract] [Full Text] [Related]
7. Presynaptic kappa-opioid and muscarinic receptors inhibit the calcium-dependent component of evoked glutamate release from striatal synaptosomes. Rawls SM, McGinty JF, Terrian DM. J Neurochem; 1999 Sep 01; 73(3):1058-65. PubMed ID: 10461895 [Abstract] [Full Text] [Related]
8. Specific inhibitory effect of amyloid-beta on presynaptic muscarinic receptor subtypes modulating neurotransmitter release in the rat nucleus accumbens. Grilli M, Lagomarsino F, Zappettini S, Preda S, Mura E, Govoni S, Marchi M. Neuroscience; 2010 May 05; 167(2):482-9. PubMed ID: 20144691 [Abstract] [Full Text] [Related]
9. Noradrenaline release from rat sympathetic neurones triggered by activation of B2 bradykinin receptors. Boehm S, Huck S. Br J Pharmacol; 1997 Oct 05; 122(3):455-62. PubMed ID: 9351501 [Abstract] [Full Text] [Related]
10. Effects of verapamil on the release of different neurotransmitters. Sitges M, Reyes A. J Neurosci Res; 1995 Apr 01; 40(5):613-21. PubMed ID: 7602614 [Abstract] [Full Text] [Related]
11. Release of dopamine from striatal synaptosomes. Raiteri M, Cerrito F, Cervoni AM, Del Carmine R, Ribera MT, Levi G. Ann Ist Super Sanita; 1978 Apr 01; 14(1):97-110. PubMed ID: 227308 [Abstract] [Full Text] [Related]
12. Inhibitory effects of amphetamine on potassium-stimulated release of [3H]dopamine from striatal slices and synaptosomes. Bowyer JF, Masserano JM, Weiner N. J Pharmacol Exp Ther; 1987 Jan 01; 240(1):177-86. PubMed ID: 3100768 [Abstract] [Full Text] [Related]
13. Reconstitution of muscarinic modulation of the KCNQ2/KCNQ3 K(+) channels that underlie the neuronal M current. Shapiro MS, Roche JP, Kaftan EJ, Cruzblanca H, Mackie K, Hille B. J Neurosci; 2000 Mar 01; 20(5):1710-21. PubMed ID: 10684873 [Abstract] [Full Text] [Related]
14. Heterogeneity of presynaptic muscarinic receptors regulating neurotransmitter release in the rat brain. Raiteri M, Leardi R, Marchi M. J Pharmacol Exp Ther; 1984 Jan 01; 228(1):209-14. PubMed ID: 6141277 [Abstract] [Full Text] [Related]
16. Heterogeneity of muscarinic autoreceptors and heteroreceptors in the rat brain: effects of a novel M1 agonist, AF102B. Ono S, Saito Y, Ohgane N, Kawanishi G, Mizobe F. Eur J Pharmacol; 1988 Oct 11; 155(1-2):77-84. PubMed ID: 3243333 [Abstract] [Full Text] [Related]
17. Dopamine D-2 autoreceptors regulating the release of dopamine from cultured rat fetal dopaminergic neurons do not desensitize upon sustained activation: implications for the combined pharmaco- and grafting therapy in parkinsonian patients. Van Muiswinkel FL, Drukarch B, Steinbusch HW, Stoof JC. Exp Neurol; 1994 Feb 11; 125(2):218-27. PubMed ID: 7906226 [Abstract] [Full Text] [Related]
20. Muscarinic potentiation of excitatory amino acid-evoked dopamine release in mesencephalic cells: specificity for the NMDA response and role of intracellular messengers. Allaoua H, Chaudieu I, Alonso R, Quirion R, Boksa P. Synapse; 1993 Sep 11; 15(1):39-47. PubMed ID: 8310424 [Abstract] [Full Text] [Related] Page: [Next] [New Search]